Taking a Clear View – Efficacy and Durability of Aflibercept in Neovascular Age-related Macular Degeneration
Neovascular age-related macular degeneration (nAMD) is highly prevalent particularly among elderly populations worldwide, and early treatment is imperative to prevent devastating progressive irreversible vision loss and eventual legal blindness.1–3 It is important that patients‘ vision is maintained in nAMD rather than following the deteriorating course that characterises the disease. Several anti-vascular endothelial growth factor (VEGF) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!